...
首页> 外文期刊>RSC Advances >Chemical fingerprinting and quantitative monitoring of the doping drugs bambuterol and terbutaline in human urine samples using ATR-FTIR coupled with a PLSR chemometric tool
【24h】

Chemical fingerprinting and quantitative monitoring of the doping drugs bambuterol and terbutaline in human urine samples using ATR-FTIR coupled with a PLSR chemometric tool

机译:使用ATR-FTIR与PLSR Chemometric工具相结合的掺杂药物Bambuterol和Terbutaline在人尿样中的化学指纹和定量监测

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The use of performance-enhancing drugs is prohibited in sports competitions according to the World Anti-Doping Agency (WADA) regulations. Here, ATR-FTIR spectroscopy coupled with a partial least squares regression (PLSR) chemometric tool was used for the detection of the misuse of such substances. Bambuterol and its metabolite terbutaline have been included in the list of prohibited doping agents. Therefore, we used bambuterol and terbutaline as models for the accurate and simultaneous qualitative and quantitative analysis of bambuterol and terbutaline in human urine samples. The method was straightforward and once the urine samples were collected, they could be directly applied to the surface of the ZnSe prism (ATR unit) to get the results within one minute. A calibration set with a partial factorial design was used to develop the PLSR model that could be used to predict the concentration of unknown samples containing the two drugs. The developed method was carefully validated and successfully applied to the urine sample analysis of human volunteers. The drugs were quantified at nanogram level concentrations. A side-by-side comparison of the proposed method with the routine GC-MS method was performed to demonstrate the challenges and opportunities of each method.
机译:根据世界反兴奋剂机构(WADA)法规,在体育比赛中禁止使用性能增强药物。这里,用局部最小二乘回归(PLSR)化学工具耦合的ATR-FTIR光谱用于检测这些物质的误用。 Bambuterol及其代谢物特许林已包含在禁止的掺杂剂清单中。因此,我们使用Bambuterol和Terbutaline作为模型的模型,用于对人尿样中的准确和同时同时定性和定量分析的人类尿液中的甜菜碱和特许林。该方法直截了当,一旦收集尿液样品,可以直接施加到ZnSe棱镜(ATR单元)的表面上以在一分钟内得到结果。使用部分因子设计的校准集用于开发可用于预测包含两种药物的未知样品的浓度的PLSR模型。经过仔细验证开发的方法,并成功地应用于人类志愿者的尿液样本分析。药物在纳米级浓度下量化。进行了与常规GC-MS方法的提出方法的并排比较,以证明每种方法的挑战和机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号